These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 4426026

  • 1. 1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapy.
    Lokich JJ, Skarin AT, Frei E.
    Cancer; 1974 Nov; 34(5):1593-7. PubMed ID: 4426026
    [No Abstract] [Full Text] [Related]

  • 2. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037).
    Einhorn LH, Livingston RB, Gottlieb JA.
    Cancer Chemother Rep; 1973 Nov; 57(4):437-45. PubMed ID: 4586951
    [No Abstract] [Full Text] [Related]

  • 3. Proceedings: Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma. A Southwest Cancer Chemotherapy study Group study.
    Gottlieb JA, Rivkin SE, Spigel SC, Hoogstraten B, O'Bryan RM, Delaney FC, Singhakowinta A.
    Cancer; 1974 Feb; 33(2):519-26. PubMed ID: 4812769
    [No Abstract] [Full Text] [Related]

  • 4. Initial clinical trials with methyl-CCNU 1-(2-chlorethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU).
    Young RC, Walker MD, Canellos GP, Schein PS, Chabner BA, DeVita VT.
    Cancer; 1973 May; 31(5):1164-9. PubMed ID: 4705154
    [No Abstract] [Full Text] [Related]

  • 5. 1-2(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU, NSC-79037): a comparison of drug administration at four-week and six-week intervals.
    Broder LE, Hansen HH.
    Eur J Cancer (1965); 1973 Feb; 9(2):147-52. PubMed ID: 4717488
    [No Abstract] [Full Text] [Related]

  • 6. Difficulties designing clinical trials as exemplified by a phase 2 drug evaluation of 5(3,3-bis(2-chloroethyl)-1-triazenol)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in patients with disseminated breast cancer.
    Ahmann DL, Bisel HF, Hahn RG.
    Cancer Res; 1973 Jul; 33(7):1707-10. PubMed ID: 4578655
    [No Abstract] [Full Text] [Related]

  • 7. A phase 2 evaluation of 1-(2-chloroethyl)-3-(4- methylcyclohexyl)-1-nitrosourea (NSC 95441) in patients with advanced breast cancer.
    Ahmann DL, Bisel HF, Hahn RG.
    Cancer Res; 1974 Jan; 34(1):27-30. PubMed ID: 4809462
    [No Abstract] [Full Text] [Related]

  • 8. A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma.
    Alberto P, Barrelet L, Chapuis B, Garcia B.
    Eur J Cancer (1965); 1975 Nov; 11(11):795-9. PubMed ID: 767111
    [No Abstract] [Full Text] [Related]

  • 9. Physiologic disposition of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (Me CCNU) in man.
    Sponzo RW, DeVita VT, Oliverio VT.
    Cancer; 1973 May; 31(5):1154-6. PubMed ID: 4705152
    [No Abstract] [Full Text] [Related]

  • 10. Phase I clinical trial of a new anthracycline: 4'-o-tetrahydropyranyl adriamycin.
    Ogawa M, Miyamoto H, Inigaki J, Horikoshi N, Ezaki K, Inoue K, Ikeda K, Usui N, Nakada H.
    Invest New Drugs; 1983 May; 1(2):169-72. PubMed ID: 6678865
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
    Klaassen DJ, Rapp E.
    Cancer Chemother Rep; 1974 May; 58(5 Pt 1):667-9. PubMed ID: 4426046
    [No Abstract] [Full Text] [Related]

  • 12. CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study.
    Hoogstraten B, Gottlieb JA, Caoili E, Tucker WG, Talley RW, Haut A.
    Cancer; 1973 Jul; 32(1):38-43. PubMed ID: 4716783
    [No Abstract] [Full Text] [Related]

  • 13. [A phase I trial of 4'-epiadriamycin].
    Ogawa M, Ikeda K, Inagaki J, Horikoshi N, Inoue K, Nakada K, Usui N, Okada Y, Adachi K, Tada A.
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
    [Abstract] [Full Text] [Related]

  • 14. Nitrosourea combination chemotherapy: 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (methyl-CCNU) and cyclophosphamide.
    Lokich JJ, Skarin AT.
    Oncology; 1975 Apr; 32(3-4):169-74. PubMed ID: 768852
    [Abstract] [Full Text] [Related]

  • 15. Lomustine treatment of metastatic renal cell carcinoma.
    Mittelman A, Albert DJ, Murphy GP.
    JAMA; 1973 Jul 02; 225(1):32-5. PubMed ID: 4740302
    [No Abstract] [Full Text] [Related]

  • 16. Adriamycin and 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the treatment of metastatic breast cancer.
    Waterfield WC, Tashima CK, Hortobagyi GN, Blumenschein GR, Buzdar AU, Burgess MA.
    Cancer; 1978 Apr 02; 41(4):1235-9. PubMed ID: 638989
    [Abstract] [Full Text] [Related]

  • 17. Combination chemotherapy with 1-(2-chloroethyl-3-cyclohexyl-1-nitrosourea) (CCNU), vincristine and methotrexate in primary and metastatic brain tumors--a preliminary report.
    Hildebrand J, Brihaye J, Wagenknecht L, Michel J, Kenis Y.
    Eur J Cancer (1965); 1973 Sep 02; 9(9):627-34. PubMed ID: 4803230
    [No Abstract] [Full Text] [Related]

  • 18. Preliminary clinical trial of 1-(2-chlorethyl)-3-(4-methylcyclohexyl)-1 nitrosourea (NSC-95411) (MeCCNU) in human neoplasms.
    Gailani S, Kutcher J.
    J Med; 1973 Sep 02; 4(4):209-18. PubMed ID: 4520348
    [No Abstract] [Full Text] [Related]

  • 19. A clinical trial of CCNU (1-(2 chloroethyl)-3-cyclohexyl-1-nitrosourea) (NSC 79037) in advanced ovarian carcinoma.
    Sasaki TM, McConnell DB, Moseley HS, Merhoff GC, Fletcher WS.
    J Surg Oncol; 1975 Sep 02; 7(5):347-50. PubMed ID: 1100915
    [Abstract] [Full Text] [Related]

  • 20. Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lung.
    Wilson WL, Andrews NC, Frelick RW, Nealon TF, Bick RL, Adams T.
    Cancer Treat Rep; 1976 Mar 02; 60(3):269-71. PubMed ID: 816467
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.